Nicholas Frankel

Company: Senti Biosciences Inc.

Job title: Director, Research

Seminars:

Engineering Next-Generation CAR cell Therapies to Navigate Challenges in Liquid & Solid Tumors 1:45 pm

SENTI-202 is a CAR-NK cell therapy that uses logic gated gene circuits to address these challenges and has shown positive preliminary clinical data in AML Solid tumors pose additional challenges. Senti has leveraged high throughput screening and machine learning to engineer next generation gene circuits, which work in both T and NK cells, designed for…Read more

day: Day Two - Track A PM